Q1 2020 Earnings Call

[music].

Good morning, ladies and gentlemen.

Welcome to accumulate therapeutics innovate topline data read out calls.

And its first quite a financial results and business highlights conference call. As a reminder, this call is being recorded.

I would now like to introduce your host for today's conference Kristen Sheppard.

Thank you and good morning.

My name is Kristen Sheppard senior Vice President of Investor Relations at a key via.

Thank you so much for joining us to discuss if you'd be a topline data from innovate our global phase three program of our product candidate by disease that the treatment of in union due to chronic kidney disease in adults.

Dialysis.

Patients.

On todays call. We will also discuss it keep these first quarter.

Yeah.

I'm in 25, yeah.

Okay.

Yeah.

<unk> <unk>.

Yeah.